Authors’ Reply to Langford et al.: “Patient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing”

• Published in: Drugs & aging Vol. 41; no. 1; pp. 79 - 80
• Main Authors: Kelley, Casey J., Niznik, Joshua, Busby-Whitehead, Jan, Ferreri, Stefanie P., Armistead, Lori T., Hughes, Tamera D., Henage, Cristine B., Schlusser, Courtney, Roberts, Ellen
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 2024; Springer Nature B.V
• Subjects: Aging; Analgesics; Analgesics, Opioid - therapeutic use; Attitudes; Benzodiazepines; Benzodiazepines - adverse effects; Clinical medicine; Conflicts of interest; Consent; Deprescriptions; Disease control; Disease prevention; Geriatrics/Gerontology; Health Knowledge, Attitudes, Practice; Humans; Internal Medicine; Letter to the Editor; Medicine; Medicine & Public Health; Narcotics; Pharmacology/Toxicology; Pharmacotherapy
• ISSN: 1170-229X; 1179-1969
• DOI: 10.1007/s40266-023-01087-5

Patients' lack of knowledge regarding their own usage of opioids, benzodiazepines, and other high-risk medications, as observed in our study [2], is likely to be detrimental to their acceptance of deprescribing as it precludes an awareness of the potential dangers of their own medications. The funders were not involved in the design of the study, collection, analysis, interpretation of the data, or in the writing of the manuscript. Ethics approval This study was approved by the Institutional Review Board of the University of North Carolina at Chapel Hill (IRB # 18-2920).